Klaria Pharma Holding AB (KLAR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.004x

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has a cash flow conversion efficiency ratio of 0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-82.00K ≈ $-8.82K USD) by net assets (Skr-20.61 Million ≈ $-2.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Klaria Pharma Holding AB market capitalisation for the company's overall valuation and market capitalisation.

Klaria Pharma Holding AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Klaria Pharma Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Klaria Pharma Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Klaria Pharma Holding AB ranked by their cash flow conversion efficiency. Explore Klaria Pharma Holding AB cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
New York City REIT Inc NYSE:NYC	-0.046x
Sejoong Co. Ltd KQ:039310	-0.005x
IRLAB Therapeutics AB (publ) ST:IRLAB-A	-0.787x
Hank Payments Corp V:HANK	0.083x
Vereinigte Filzfabriken AG MU:VFF	N/A
Alta Zinc Limited F:8EE	-0.151x
Dataprep Holdings Bhd KLSE:8338	-0.366x
Fusemachines Inc. Common stock NASDAQ:FUSE	1.481x

Annual Cash Flow Conversion Efficiency for Klaria Pharma Holding AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Klaria Pharma Holding AB from 2015 to 2025. View Klaria Pharma Holding AB (KLAR) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-3.88 Million ≈ $-417.44K	Skr-35.04 Million ≈ $-3.77 Million	9.032x	+350.12%
2024-12-31	Skr3.31 Million ≈ $355.67K	Skr-11.94 Million ≈ $-1.28 Million	-3.611x	-1539.91%
2023-12-31	Skr41.13 Million ≈ $4.43 Million	Skr-9.06 Million ≈ $-974.79K	-0.220x	+66.31%
2022-12-31	Skr76.08 Million ≈ $8.19 Million	Skr-49.73 Million ≈ $-5.35 Million	-0.654x	-82.97%
2021-12-31	Skr69.42 Million ≈ $7.47 Million	Skr-24.80 Million ≈ $-2.67 Million	-0.357x	-10.92%
2020-12-31	Skr109.59 Million ≈ $11.79 Million	Skr-35.30 Million ≈ $-3.80 Million	-0.322x	-78.73%
2019-12-31	Skr82.11 Million ≈ $8.84 Million	Skr-14.80 Million ≈ $-1.59 Million	-0.180x	-86.99%
2018-12-31	Skr94.70 Million ≈ $10.19 Million	Skr-9.13 Million ≈ $-982.10K	-0.096x	-22.67%
2017-12-31	Skr153.52 Million ≈ $16.52 Million	Skr-12.06 Million ≈ $-1.30 Million	-0.079x	+12.65%
2016-12-31	Skr160.04 Million ≈ $17.22 Million	Skr-14.39 Million ≈ $-1.55 Million	-0.090x	-254.52%
2015-12-31	Skr174.59 Million ≈ $18.79 Million	Skr-4.43 Million ≈ $-476.63K	-0.025x	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$15.75 Million

Skr146.36 Million SEK

Market Cap Rank

#25937 Global

#531 in Sweden

Share Price

Skr0.60

Change (1 day)

+0.17%

52-Week Range

Skr0.46 - Skr1.22

All Time High

Skr17.00